Chonluten in chronic bronchitis: Medical Center clinical report
Comparison in people · 2006
- What was studied
- 42 adults aged 38–65 with chronic bronchitis and an asthmatic component: 23 received adjunctive Chonluten and 19 received conventional therapy.
- Main finding
- The report lists forced expiratory vital capacity of 3,800.8 mL after adjunctive Chonluten versus 3,200.7 mL after conventional care. It marks the former against a shared baseline of 2,850.6 mL.
Forced expiratory vital capacity · 3,800.8 ± 136.9 mL with Chonluten vs 3,200.7 ± 187.5 mL with conventional care. Shared baseline 2,850.6 ± 158.4 mL. · The Chonluten value is marked p < 0.05 versus baseline.
Reported findings and study design
23 patients received adjunctive Chonluten and 19 received conventional treatment. The methods give no tested regimen. The later recommendations list two different courses.
Population or model 42 adults aged 38–65 with chronic bronchitis and an asthmatic component: 23 received adjunctive Chonluten and 19 received conventional therapy.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Forced expiratory vital capacity | 3,800.8 ± 136.9 mL with Chonluten vs 3,200.7 ± 187.5 mL with conventional care. Shared baseline 2,850.6 ± 158.4 mL. | The Chonluten value is marked p < 0.05 versus baseline. |
| Vital capacity | 4,150.4 ± 265.6 mL with Chonluten vs 3,950.3 ± 298.12 mL with conventional care. | The table gives no significance mark for this outcome. |
| Reported symptom improvement | 73% in the Chonluten group. The report gives no comparator percentage or prespecified response scale. |
The spirometry comparison uses a shared baseline and supplies no between-group test.
Source for these results ↗ · Reviewed 2026-11-16
Study limitations and source details
Study limitations
- The report gives one shared baseline and leaves allocation and masking unspecified.
- The methods give no study dosing schedule. The recommendations list conflicting schedules.
- The reported treatment course gives limited safety information and insufficient characterization to establish equivalence with synthetic EDG.
Source details
Institute report / commercial reproduction
Report reproduction, PDF pages 123–125. Population, symptom results and Table 1.
Sources checked
Citation
Report attributed to · Medical Center, St. Petersburg Institute of Bioregulation and Gerontology
Originating institute; report reproduced in commercial collection. Chonluten in chronic bronchitis: Medical Center clinical report Reports on clinical studies of CYTOMAX and CYTOGEN products; PDF page 123